![Frontiers | Immunoglobulin and T Cell Receptor Genes: IMGT® and the Birth and Rise of Immunoinformatics Frontiers | Immunoglobulin and T Cell Receptor Genes: IMGT® and the Birth and Rise of Immunoinformatics](https://www.frontiersin.org/files/Articles/78999/fimmu-05-00022-HTML-r2/image_m/fimmu-05-00022-g001.jpg)
Frontiers | Immunoglobulin and T Cell Receptor Genes: IMGT® and the Birth and Rise of Immunoinformatics
![A diagram of intact immunoglobulin showing the structure of the heavy... | Download Scientific Diagram A diagram of intact immunoglobulin showing the structure of the heavy... | Download Scientific Diagram](https://www.researchgate.net/publication/292707470/figure/fig1/AS:324773956603911@1454443554022/A-diagram-of-intact-immunoglobulin-showing-the-structure-of-the-heavy-and-light-chains.png)
A diagram of intact immunoglobulin showing the structure of the heavy... | Download Scientific Diagram
![IgM, Kappa from murine myeloma clone TEPC 183, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich IgM, Kappa from murine myeloma clone TEPC 183, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich](https://www.sigmaaldrich.com/deepweb/content/dam/sigma-aldrich/product2/081/iga_k-illustration.eps/_jcr_content/renditions/iga_k-illustration-medium.jpg)
IgM, Kappa from murine myeloma clone TEPC 183, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich
![IgG2a, Kappa from murine myeloma clone UPC 10, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich IgG2a, Kappa from murine myeloma clone UPC 10, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich](https://www.sigmaaldrich.com/deepweb/content/dam/sigma-aldrich/product7/105/igg2a_k-illustration.eps/_jcr_content/renditions/igg2a_k-illustration-medium.jpg)
IgG2a, Kappa from murine myeloma clone UPC 10, purified immunoglobulin, buffered aqueous solution | Sigma-Aldrich
![Rearrangement of Mouse Immunoglobulin Kappa Deleting Element Recombining Sequence Promotes Immune Tolerance and Lambda B Cell Production: Immunity Rearrangement of Mouse Immunoglobulin Kappa Deleting Element Recombining Sequence Promotes Immune Tolerance and Lambda B Cell Production: Immunity](https://www.cell.com/cms/attachment/663befcf-39f1-4d3d-a130-292c8d176ace/gr1_lrg.jpg)
Rearrangement of Mouse Immunoglobulin Kappa Deleting Element Recombining Sequence Promotes Immune Tolerance and Lambda B Cell Production: Immunity
![What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms](https://i1.wp.com/www.differencebetween.com/wp-content/uploads/2022/03/Four_Chain_Structure_of_a_Generic_Antibody-IgG2_Structures.jpg?resize=553%2C220&ssl=1)
What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms
Structure of a normal immunoglobulin (Ig) molecule. Each immunoglobulin... | Download Scientific Diagram
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/3df9a166-9499-4800-a9f7-49e5fac85081/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells | Molecular Cancer | Full Text LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1476-4598-8-92/MediaObjects/12943_2009_Article_477_Fig2_HTML.jpg)